Green Sky Labs Investor Presentation

25 pages
8 downs
328 views

Extension: PDF

Please download to get full document.

View again

of 25
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Share
Description
In a dynamic and rapidly changing industry, GSL has seized on the opportunity to apply superior scientific expertise, our unique products and patented technologies to enhance quality and efficacy in the development of cannabinoid medicines, products and plant cultivation.
Transcript
  • 1. Confidential – Green Sky Labs www.GreenSkyLabs.com InvestorPresentation February2017 The Science of Changing Lives
  • 2. Disclaimer 2 This management presentation is intended to provide an overview of the business of Green Sky Labs Inc. (“Green Sky”). It has been prepared for information purposes only and does not purport to be complete. The presentation contains statements that, to the extent that they are not historical fact, may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements in this presentation include, but are not limited to, statements regarding Green Sky potential acquisition growth and Green Sky’s beliefs regarding the future prospects for the medical marijuana industry. In addition to these statements, any statements regarding future plans, objectives, or economic performance of Green Sky, or the assumption underlying any of the foregoing, constitute forward-looking information. This presentation uses words such as “may”, “would”, “will”, “likely”, “expect”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, and other similar expressions to identify forward-looking statements. Actual results, performance, or achievement could differ materially from that expressed in, or implied by, any forward-looking statements in this presentation, and accordingly, readers should not place undue reliance on any such forward-looking statements. Forward-looking involves significant risks, assumptions, uncertainties, and other factors that accordingly, should not be read as guarantees of future performance or results. These risks and uncertainties include the business of acquiring and owning real property including the following: government regulation and environmental matters; illiquidity; uninsured losses; investment concentration; competition; acquisition strategy; reliance on key personnel; integration of additional properties; debt financing; interest rates; litigation; restrictive covenants; joint venture investments; potential undisclosed liabilities associated with acquisitions; reliance on external sources of capital and other factors. Due to the potential impact of these factors, any forward-looking statements speak only as of the date on which such information is made and Green Sky disclaims any intention or obligation to update or revise any forward- looking information, and it is not possible for management to predict all of such factors and to assess in advance the impact of each factor on Green Sky’s business or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statements. Investments have risks – Principal and Returns not Guaranteed. Forward Looking Statement Confidential – Green Sky Labs
  • 3. Introduction Green Sky Labs Inc. (GSL) is a technology leader in the hemp and marijuana industries. GSL’s proprietary isolation technology along with its highly qualifiedmanagement team, positions the company to take advantageof the rapid growth of the industry. Privateplacementcurrentlybeing offeredpriortoanticipatedpubliclistingin 2017. Publicofferingsandspinoffsplannedforpharmaceuticalandotherdivisions. 9 millionshares offeredat $1.35CADwitha pre-moneyvaluationof $68.5M. 51 millionsharescurrently outstanding. 3 Victoria InnovationAdvancedTechnology andEntrepreneurshipCouncil 2016 StartUpof the Year Head Office: Victoria, BC Satellite Offices: Vancouver, BC andToronto, ON Incorporated:Calgary, AB Our Company Confidential – Green Sky Labs
  • 4. Introduction • Green Sky Labs Inc. has signed an exclusive global licensing agreement with Petro Sep Corp out of Oakville, Ontario, to allow the use of Petro Sep’s proprietary membrane technology for the large scale production of CBD and THC. This 25 year global exclusivity will allow GSL to be the world leader in cannabinoid isolate production as the company would be able to produce the isolates at a fraction of the cost of current technologies. The multi-billion dollar industry in cannabinoid isolates is growing significantly as many jurisdictions are legalizing cannabis, particularly in the medicinal space. • This isolation technology allows GSL to produce innovative pharmaceuticals and a number of clinical trials are planned with leading researchers in their respective fields. Clinical trials for treatments of pain, ALS, post traumatic stress disorder are planned as well a natural replacement for a synthetic THC drug. • GSL is partnering with IBM Watson to develop a web portal to provide alternative treatments such as cannabis based pharmaceuticals and nutraceuticals to counter the opioid epidemic that is occurring across North America. Cannabis related treatments may offer the best alternative to opioid based pharmaceuticals. • GSL is partnering with leading producers across the United States as well as with a major cannabis development to provide their extraction and isolation services. GSL plans to build out its isolation facility in major global markets. 4 Executive Summary Confidential – Green Sky Labs
  • 5. Clear strategy across each of Green Sky Labs two (2) unique divisions touchingboth of the lucrative hemp andcannabis industries of pharmaceuticalR&D, extraction & isolationtechnologies. Breakthrough world-wide patented technology in extraction, isolation and scaling services forCBDandTHC to 99.9% purity and large scale production. Production facilitiesin Europe and United States. Exploring strategic partnershipsin other regions such asSouthAmerica and Australia. Partnered with IBM Watson forDrug Discovery. Thefirstdrug discovery company in the cannabismarketto utilize andwork with a platform for “Data-driven drugdesign.” NaturalDronabinoil(syntheticMarinol replacement) targetedapproval date by the FDA in early 2019. Financial forecastsof isolatesales of CBD andTHC showsignificant revenue and earningsover next several years. Green Sky Labs Pharmaceutical division has significantupside potential basedan comparablefirmslisted on US exchanges. IPO in 2017 forboth divisionsexpected. Pharmato be onUS exchange and parent company onCanadianexchange. Introduction 5 MultipleBusiness Lines Extraction &Isolation Pharmaceuticals “Company’s unique proprietary isolation technology allows development of various lines of business in addition to the production and sale of cannabinoid isolates. These include a pharmaceutical division an alternative pain portal with IBM. Purity Ton Per Day Confidential – Green Sky Labs
  • 6. Introduction U.S. Operations CanadianOperations • GSL has just been granteda laboratory license to conductresearch and developmentinthe cannabis industry. • GSL has entered intoa strategicalliance with First Nationsof Canadafor cultivation, extraction and isolation. • GSL will be building isolationandextraction facilities with multiple strategic partnersacrossCanada. EuropeanOperations • GSL has developedstrategic alliances with hemp growers in Germany, CypressandRomania. • GSL is currently settingup operationsin the Germany to use its isolationtechnology toisolate CBD for sale in Europe andexport to the USmarkets. GSL Offices (3) Strategic Partnerships FutureStrategic Partnerships Production facilities in United States and Europe as well as Canadian laboratory license. • GSL has a locationin WashingtonStatewith licenses to cultivate andextract. • GSL will have partnershipstoextract and isolate in California as well as otherstates. • CBD is currently legal in all USstatesand can be importedfrom Europe. 6Confidential – Green Sky Labs
  • 7. Market Overview 7 GlobalHemp Industry $1.5 Trillion 2015 GlobalHemp Industry. ConsumerMarket:IncludingPharmaceuticals $50 Billion Cannabidiol(CBD) Pharmaceuticals Marketby 2020 Confidential – Green Sky Labs
  • 8. Market Overview GlobalCBD Industry CBD is a key Ingredientin Cannabis CBD is Non- Psychoactive CBD hasa wide range of Medical Benefits “CBD’s appeal to consumers is that it is a THC-free, non-psychoactive compound derived from hemp which has many of the same medicinal properties found in marijuana, as well as others not attributed to marijuana, but without the psychoactive side effects, or “high.” CBD is one of over 60 compoundsfoundincannabisthat below to a class of molecules called cannabinoids. Of these compoundsCBDandTHC are usually presentin the highestconcentrations, andare therefore the most recognized andstudied. UnlikeTHC, CBD does notcause a high becauseit does notact onthe same pathwaysasTHC. Numerousstudies suggestthatCBD acts to reduce the intoxicating effects of THC, suchas memory impairmentand paranoia. Studies have found CBD to possess the following medical properties: • Anticonvulsant (suppress seizure activity) • Antipsychotic (combats psychosis disorders) • Anti-inflammatory (combats inflammatory disorders) • Anti-tumoral (combats tumor and cancer cells) 14Confidential – Green Sky Labs
  • 9. Market Overview 9 $50+ Billion Market by 2020. 45+ Million Consumers by 2020. ConsumerMarket:Recreationaland Medicinal Global MarijuanaIndustry Proven Uses for Medical Marijuana Alzheimer’s Tourette’sSyndrome Sleep Apnea Hypertension Hepatitis C Diabetes HIV Osteoporosis RheumatoidArthritis Incontinence ChronicPain Fibromyalgia Glaucoma MS, Cerebral Palsy, SpinalInjury Asthma Painrelief Anti-nauseafor Cancer Patientsand Appetite Stimulationin cancer patients ProvenUses EmergingUses Confidential – Green Sky Labs
  • 10. Core Business Lines Isolation Technology Extraction & Isolation 10 Pharmaceuticals IsolationTechnology and PharmaceuticalDivisions 1 • Developingnew pharmaceutical dosage forms of cannabinoidmedication • Research anddevelopmentin the areas of immunology andinflammation, oncology, neurology, neuroscienceand pain, and anxiety disorders. • Multiplephase II studiesin progress. • Firstdrug targetedforapproval bythe FDA inQ1 2019. Pharmaceutical • Globally patentedextraction, isolationand scale-uptechnology with significant cost advantage. • Uniqueextraction thatmaintainsthe full terpene, flavonoidandcannabinoidprofile andpreserves entourageeffect and original flavourof bud. • Can usehemp as feedstock, covert CBDto THC andproduce 99.9% purity atsignificant cost advantage. We can storeCBD and THC in crystalform. 2 Confidential – Green Sky Labs
  • 11. Complementary Business Lines AskWatsonPain.com California Joint Venture 11 IBM Partnership, LaboratoryServices and California Joint Venture 1 • GSL is currently in an agreement with IBM Watson to develop the only Complementary and Alternative Medicine pain portal built on cognitive technology. • GSL is aggressively expanding its technology division. This division is headed by four (4) technology industry veterans that have a track record in creating billions of dollars in ROI in trend setting world class technology companies. Coachillin Business Park • GSL has already established direct manufacturing links to proven suppliers in China from one of our lead investors. We have established exclusive agreements to source certified and quality products in the following areas and provide them to the Coachillin’ Business Park (a 4M sq. foot cultivation facility in California): o Extraction & IsolationServices o Fertilizer o Lighting technologies o Environmental controls o Consumable products 3 IBM Partnership Licensed Victoria Laboratory • GSL has become one of the first Health Canada approved Medical Cannabis testing and analytics labs (in British Columbia). • GSL can provide testing and analyze medical/ recreational marijuana to ensure compliance with public safety standards. • In addition to this our Lab also completes R&D innovation of its own highly-differentiated and proprietary products. 2 Laboratory Services Confidential – Green Sky Labs
  • 12. Extraction and Isolation 12 Global Patents Extraction, isolation and scale-up technology patents in process or to be submitted in beginning of 2017. Cost Advantage Our proprietary technology solution allowing extraction and isolation of cannabinoids such as CBD and THC at a significant cost advantage over traditional methods. Unique Extraction Unique Isolation Extraction technology process is unique in the fact that we are able to: • Maintain the full terpene,flavonoid and cannabinoid profile. • Preservesentourage effect and original flavour of bud. Isolation technology process can use hemp as feedstock, covert CBD to THC and produce 99.9% purity at a significant cost advantage. We can store CBD and THC in crystal form. Demand for CBD will outpace production for the remainder of the decade resulting in what Green Sky Labs believes to be one of the most exciting and profitable investment opportunities currently available. Unique Differentiators Confidential – Green Sky Labs
  • 13. Extraction and Isolation Can be extractedfromone hectare areaof a Hempfield(2.5Acres). 230kg CBD Wholesale price pointof CBD(basedonmarketrates). $15k per kilo $3.45M per hectare twice a year. $6.9m Revenue GOLD $45/gram MarketPrice 5/10/2016 CBD $90/gram Retail Value 20 Acresof Hempwill produce 4,000 lbs.of CBD per year. At currentwholesale prices,4,000 lbs.of CBD isvaluedat $25+ million. To put thisinperspective,4,000 lbs.of CBD wouldeasilyfitinthe bedof apickuptruck. $25 milliononlyaccountsfor<1% of the projected2020 market. 13 Production Capabilitiesfor Existing Proprietary Green Sky Labs Technologyof up to 5KG per Day Confidential – Green Sky Labs
  • 14. Extraction and Isolation 14 • Oil extraction equipmentpurchased in September, 2016. • $4.3M capitalinvestmentto date. • Perfected extraction, isolation and scale up technologies. • Can use hemp as feedstock (even trim) to convertto 99.9%purity. • Can maintain fullterpene, flavonoid and cannabinoid profile. • Can storeboth CBD and THC in crystal form. $226M 20% Capacity $544M40% Capacity $270M Pre-Tax Earnings for CBD Pre-Tax Earnings for THC $574M Production $1.09B80% Capacity $1.15B $1.36B100% Capacity $1.44B • Assume CBD averagesales price per Kilo is $10,000. • Assume THCaveragesales priceper Kilo is $25,000. • Cost to build and operateGreen Sky Labs production facilityis $7M. • Production facilityamortized over 25 years. • Will take 9 months to have our first facility built. • Targetdatefor firstplantis second half of 2017. Production Capabilitiesfor Membrane Technology CDB and THC Isolate Projected Earningsper Isolate The Numbers Confidential – Green Sky Labs
  • 15. Extraction and Isolation 15 E-34 HEATER CONDENSER FIRST CUT SOLVENTS 90- 95% SECOND CUT WATER WITH SOLVENTS 10-15% V-13 1 LITER FEED E-39 HEATER MIXTURE FROM STAGE 1 CBD/THC STAGE 1 STAGE 2 CONDENSER GlobalPatent: Membrane Scale Up Technology In the stage 1 CBD/THC extract will be heated with water. After 1 hour of heating, dehydration by Green Sky Labs technology will start. After dehydration, the mixture will be transferred to stage 2 for fractionation. 1 2 In stage 3, the wet CBD/THC will be transfer to Green Sky Labs technology to dehydrate CBD/THC to 99.0 % or more. 3 TypicalMethods Butane Hash Oil, commonlyreferred to as BHO, is a type of cannabis concentrate made using butane as the mainsolvent. BHO WATER PatentedTechnology PatentedTechnology These present many health and safety (i.e.- fire) risks. Confidential – Green Sky Labs Carbon dioxide (CO2) is a supercritical fluid, meaning it converts into a liquid form when pressurized. CO2 Columns A method used to to purify chemical compounds from a mixture of compounds, manyparts, maysteps that may include helium, hydrogen, methanol or acetonitrile). Multi-Kilo Feed
  • 16. Pharmaceutical Division The pharmaceuticaldivision of Green Sky Labs will be focus on research and developmentalong with clinical trials for selected treatments using custom formulations based on our isolation technology. In additionthe division is partnering with IBM Watson for Drug Discovery to be the first company in the Cannabis market utilize and develop a platform for data-drivendrug design. 16 Immunology & Inflammation Oncology Neurology Neuroscience Pain & Anxiety Introduction We focus prioritizing our research and development efforts in the following areas: Confidential – Green Sky Labs
  • 17. Pharmaceutical Division Usedto treatnausea and vomiting caused by chemotherapy. Usedto treatlossof appetite and weight loss in people who have acquired immunodeficiency syndrome (AIDS). It worksby affecting the area of the brainthat controlsnausea, vomiting, andappetite. Why are we doing drugdiscovery? Capsules, vaporizers(closed loopmedically graded), oils, nutraceutical products. >$525 Million Total Market Size in 2015. 273K Prescriptions Written in 2015. How shouldthis medicine be used? How is this medicationprescribed? Green Sky Labs targeted FDA Approval Q1 2019 Regulatory work completed o GMP certified Manufacturers secured o CROs secured o Regulatory paperwork submitted o First volunteer secured for Q1 2017 Protectsthe motor neurons the disease kills. ImportantcannabinoidstoALSsuffers include cannabinol(CBN) andanti-convulsant, tethrahydrocannabivarin(THCV)an anti- inflammatory, cannabichormene(CBC)an anti-inflammatory, analgesic(painkiller) and promotesbraingrowth, and cannbicyclol (CBL) a pain killer. . Why are we doing drugdiscovery? Inhalation, edibles, tinctures, topicalsand Oils. >$6 Billion Total Market Size in 2015. 5,000 People Diagnosed Each Year. How is this medicationprescribed? Green Sky Labs Phase II Trails Begun Usedto treatdepression, obsessive- compulsive disorder, anxiety disorders, post- traumatic stress disorder (PTSD), and premenstrual dysphoric disorder (PMDD). ReplacementfortraditionalOpioids suchas Paxil and Zoloftwhich can havebothharsh physicaland mentalside-effects. Why are we doing drugdiscovery? Edibles andCapsules. >$45 Billion Total Market Size in 2015. 10% People Worldwide Affected. How is this medicationprescribed? Green Sky Labs Phase II Trails Begun Cannabis reducestherisk of addiction to opiatespre-surgery andfollowingsurgery. Cannabiscaused few side effects, makingit especially safe for patientshavingjust undergonesurgery who often cannot tolerate conventionalpharmaceuticaldrugs Providepain relief for a variety of conditions. . Why are we doing drugdiscovery? Inhalation, edibles, tinctures, topicalsand Oils. $635 Billion Total Market Size in 2015. 116M People Diagnosed Each Year. How is this medicationprescribed? Green Sky Labs Phase II Trails Begun 17 Dronabinoil Project ALS Project PTSD Project General Pain Project Confidential – Green Sky Labs
  • 18. Pharmaceutical Division Project Diseases Treated Pre-Clinical Dronabinol THC (Marinol Replacement) ALS (Customized Formulations) PTSD (Customized Formulations) Pain Formulas (Customized Formulations) Enhanced (Customized Formulations) Chemo Induced Patients (Appetite Simulant) Zoloft & Paxil Replacement (SSRI’s) Pre-Operative & Chronic Pain (Crohn’s, Multiple Sclerosis & Epilepsy Cannabinoids and Peptides (Generic) ALS Suppressant (Motor Neuron Protection) Phase 2 Phase 3 Completed Bioequivalence Study Submit & Approve FDA ANDA, HC, ANDS, EMA FY 2016 ≥FY 2018 - 2019≥FY 2017 Initiate Phase 2 Out License Completed Bioequivalence Study FDA Fast Track, HC, DIN, EMAInitiate Phase 2 Out License Completed Bioequivalence Study Initiate Phase 2 Out License Phase 1 Completed Bioequivalence Study Initiate Phase 2 Out License Future Opportunities Research Stage 18 Project Timelines Confidential – Green Sky Labs
  • 19. Pharmaceutical Division 19 Greater Value-AddedOfferings for Pharmaceutical Drug Discovery Competitive Advantage Access to Cognitive Technology and accelerated Cannabis drug discovery. Value-Added through AI Increased company value by utilizing the WDD. We will become the leading researchers for Can
  • Related Search
    We Need Your Support
    Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

    Thanks to everyone for your continued support.

    No, Thanks